Management tracks: Ablynx, Cardiovascular Systems

Nanobody company Ablynx N.V. (Euronext:ABLX; NASDAQ:ABLX) hired Robert Friesen as CSO, effective March 1. He is SVP of science and early development at ProQR Therapeutics N.V. (NASDAQ:PRQR).

Medical device company Cardiovascular Systems Inc. (NASDAQ:CSII) said COO Kevin Kenny will leave the company at the end of the month. Rhonda Robb will succeed as COO. She was VP and general manager of the heart valve therapies business at Medtronic plc (NYSE:MDT)...